Itralent 100mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. It is effective against a wide range of pathogenic fungi, including dermatophytes, yeasts, and molds. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Itralent is indicated for the management of systemic and superficial mycoses such as aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. The capsule formulation ensures optimal bioavailability when taken with food, enhancing absorption. Dosage and duration of treatment depend on the type and severity of infection, and therapy should be guided by clinical response and mycological findings. Caution is advised in patients with hepatic impairment or congestive heart failure, as itraconazole may cause hepatotoxicity and negative inotropic effects. Drug interactions are notable due to itraconazole’s inhibition of cytochrome P450 enzymes, necessitating careful review of concomitant medications. Common adverse effects include gastrointestinal disturbances, headache, and rash. Itralent should be used under medical supervision, with monitoring for efficacy and potential side effects to ensure safe and effective antifungal therapy.